Logo image of LAWS

LAWSON PRODUCTS INC (LAWS) Stock Fundamental Analysis

NASDAQ:LAWS - Nasdaq - US5207761058 - Common Stock

40.42  -0.73 (-1.77%)

After market: 40.42 0 (0%)

Fundamental Rating

3

LAWS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 48 industry peers in the Trading Companies & Distributors industry. LAWS has a bad profitability rating. Also its financial health evaluation is rather negative. LAWS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LAWS had positive earnings in the past year.
LAWS Yearly Net Income VS EBIT VS OCF VS FCFLAWS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M 20M 30M

1.2 Ratios

Industry RankSector Rank
ROA 5.47%
ROE 10.37%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LAWS Yearly ROA, ROE, ROICLAWS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 20 30

1.3 Margins

Industry RankSector Rank
OM 5.15%
PM (TTM) 3.42%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LAWS Yearly Profit, Operating, Gross MarginsLAWS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

LAWS has about the same amout of shares outstanding than it did 1 year ago.
LAWS has a worse debt/assets ratio than last year.
LAWS Yearly Shares OutstandingLAWS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M
LAWS Yearly Total Debt VS Total AssetsLAWS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 6.47 indicates that LAWS is not in any danger for bankruptcy at the moment.
LAWS has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 6.47
ROIC/WACCN/A
WACCN/A
LAWS Yearly LT Debt VS Equity VS FCFLAWS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 2.05 indicates that LAWS has no problem at all paying its short term obligations.
A Quick Ratio of 0.97 indicates that LAWS may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 0.97
LAWS Yearly Current Assets VS Current LiabilitesLAWS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 152.87% over the past year.
Measured over the past years, LAWS shows a very strong growth in Earnings Per Share. The EPS has been growing by 153.17% on average per year.
The Revenue has grown by 18.66% in the past year. This is quite good.
Measured over the past years, LAWS shows a quite strong growth in Revenue. The Revenue has been growing by 8.59% on average per year.
EPS 1Y (TTM)152.87%
EPS 3Y16.37%
EPS 5Y153.17%
EPS Q2Q%26.67%
Revenue 1Y (TTM)18.66%
Revenue growth 3Y6.11%
Revenue growth 5Y8.59%
Sales Q2Q%13.78%

3.2 Future

The Earnings Per Share is expected to grow by 15.95% on average over the next years. This is quite good.
Based on estimates for the next years, LAWS will show a small growth in Revenue. The Revenue will grow by 4.99% on average per year.
EPS Next Y23.33%
EPS Next 2Y19.87%
EPS Next 3Y16.86%
EPS Next 5Y15.95%
Revenue Next Year6.61%
Revenue Next 2Y5.51%
Revenue Next 3Y4.81%
Revenue Next 5Y4.99%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LAWS Yearly Revenue VS EstimatesLAWS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
LAWS Yearly EPS VS EstimatesLAWS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2 3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

LAWS is valuated rather expensively with a Price/Earnings ratio of 18.37.
LAWS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.53.
The Price/Forward Earnings ratio is 13.52, which indicates a correct valuation of LAWS.
LAWS is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.37
Fwd PE 13.52
LAWS Price Earnings VS Forward Price EarningsLAWS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.87
LAWS Per share dataLAWS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

LAWS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LAWS's earnings are expected to grow with 16.86% in the coming years.
PEG (NY)0.79
PEG (5Y)0.12
EPS Next 2Y19.87%
EPS Next 3Y16.86%

More info and screens

0

5. Dividend

5.1 Amount

LAWS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LAWSON PRODUCTS INC

NASDAQ:LAWS (5/6/2022, 8:00:03 PM)

After market: 40.42 0 (0%)

40.42

-0.73 (-1.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)04-28 2022-04-28/bmo
Earnings (Next)07-27 2022-07-27
Inst Owners223.21%
Inst Owner Change0.03%
Ins Owners63.31%
Ins Owner Change0%
Market Cap784.96M
Analysts82.5
Price Target62.22 (53.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.37
Fwd PE 13.52
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B 5.5
P/tB N/A
EV/EBITDA 25.87
EPS(TTM)2.2
EY5.44%
EPS(NY)2.99
Fwd EY7.39%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS22.25
BVpS7.35
TBVpSN/A
PEG (NY)0.79
PEG (5Y)0.12
Profitability
Industry RankSector Rank
ROA 5.47%
ROE 10.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 5.15%
PM (TTM) 3.42%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.05
Quick Ratio 0.97
Altman-Z 6.47
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.87%
EPS 3Y16.37%
EPS 5Y153.17%
EPS Q2Q%26.67%
EPS Next Y23.33%
EPS Next 2Y19.87%
EPS Next 3Y16.86%
EPS Next 5Y15.95%
Revenue 1Y (TTM)18.66%
Revenue growth 3Y6.11%
Revenue growth 5Y8.59%
Sales Q2Q%13.78%
Revenue Next Year6.61%
Revenue Next 2Y5.51%
Revenue Next 3Y4.81%
Revenue Next 5Y4.99%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A